Scientific Advisory Council

Nils Lonberg, PhD

Canaan Partners

Milpitas, CA

Dr. Nils Lonberg joined the venture capital firm Canaan Partners in 2019. 

He was the senior vice president of Biologics Discovery and head of Oncology Discovery at Bristol-Myers Squibb. Previously, Dr. Lonberg led a group that developed transgenic mice which have helped scientists discover effective new medicines for humans, including five FDA-approved antibody products. In recognition of his accomplishments, he was elected to the National Academy of Engineering. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Lonberg serves on the Cancer Immunotherapy Consortium (CIC) Steering Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.